New
updated
agenda
23 - 25 March 2015
Suntec Singapore Convention & Exhibition Centre,
Singapore
Navigating the future of Asia’s
biopharmaceutical industry
www.terrapinn.com/biopharmaasia
“PROPER STRATEGIES TO
TAKE ADVANTAGE OF
THE HISTORICAL TSUNAMI,
THE RISE OF ASIA”
When you imagine Asia, what comes to mind? Porcelain, china?
Congested, dusty roads? Cheap manufacturing costs or counterfeit
markets?
Asia has long been considered an emerging market, living in the shadow of
Europe and the west. Learning from scientific breakthroughs in the US and
replicating pharma manufacturing practices from Europe has given Asia a
‘copycat’ reputation.
Christopher Gallen
President, SK Biopharmaceuticals, South Korea
Advancing Asia’s biopharmaceuticals
industry
Wednesday 25 March 2015, 09:45-10:30am
Bringing a Korean spin-off to its current 12 IND approvals (US FDA) and strong
pipelines of innovative drugs, Christopher has already taken advantage of the
opportunities within Asia-Pacific’s biopharmaceutical market. He believes that
success comes from seeing the future and getting there first, and currently Asian
pharma companies
p
p
are in a unique
q p
position to exercise his p
philosophy.
p y
Asia is producing young, exciting R&D specialists, large manufacturing
plants and copius amounts of patient data. It is time for Asia to breakaway
from it’s outdated reputation.
Green Cross Corp, based in Korea has vaccinated over 130 million people
with Hepavax, a Hepatitis B vaccine. It also developed the first epidemic
hemorragic fever vaccine, a chicken pox vaccine and the first AIDS
diagnostic reagent. Serum Institute of India led by Dr Jadhav and his team
has finally found the winning formula to manufacture large volumes of
vaccines and is now a supplier to 140 countries. Simcere Pharmaceuticals
from China has partnered with global brands like Merck & Co, and Bristol
Myers Squibb to concentrate on therapies for cardiovascular diseases. And
this is just one of China’s many companies that large MNCs are getting in
bed with.
It can no longer be said that Asia is lagging behind in the global
pharmaceutical market. With the help of leading experts, BioPharma Asia
will outline the future for Asia’s biopharma industry.
Be a part of the biopharma revolution in Asia, book online now at
www.terrapinn.com/biopharmaasia
The Big Picture
ROUNDTABLE DISCUSSIONS
KEYNOTE PRESENTATIONS
SECRET COCKTAIL PARTY
EXHIBITION
FREEMIUM AGENDA
AWARDS DINNER
ASIAN BIOTECH SHOWCASE
1-2-1 MEETINGS
This is probably the most important event in the year on
biopharma in terms of participants. It cannot be missed.
JOHNSON & JOHNSON
KEY SPEAKERS
Angeline Lau
Chih-Liang Chin
Swapnil Ballal
James Garner
James Huang
Kiyean Nam
Koike Satoshi
Regional Manager,
Clinical & Medical
Quality Operations
Director and Site Lead,
Imaging
Senior Director, Quality
Assurance
Managing Partner
Chief Executive Officer
Biocon, India
Kleiner Perkins
Caufield Byers
(KPCB), China
Qurient
Therapeutics,
South Korea
Director, Regulatory
Affairs, Japan
Merck Sharp Dohme
(MSD), Singapore
Head, Unit
Development
Operations, Asia R&D
Sanofi Pasteur,
Singapore
Sanofi, Singapore
Javed Rashid
Jessie Gu
Jianmei Kochling
Jim Miller
Jimmy Zhang
May Wei
Chief Scientific Officer
and Head of Medical
(Pharmaceuticals)
Head, Translational
Medicine, China
Director, Quality
Science and Analytical
Technology
Vice President &
Head, Biologics
Drug Substance
Manufacturing
Network
Vice President,
Transaction, Asia
Pacific
Global Regulatory
Strategist
Novartis, Singapore
Novartis Institute
for Biomedical
Research, China
Genzyme, USA
Genentech, USA
Johnson & Johnson
Innovation Center,
China
Bayer Healthcare,
China
Amgen Astellas
BioPharma KK,
Japan
Leena
Menghaney
Head, Access
Campaign, South Asia
Marcus Klein
Matsumoto Jun
Senior Director and
Regional Medical
Officer, Japan & AsiaPacific
Principal Reviewer,
Office of Cellular and
Tissue-based Products
Genzyme, Singapore
Pharmaceutical and
Medical Devices
Agency (PMDA),
Japan
Pradip Patel
Vinoop Goel
Vice President & Head,
Vaccine (Operations &
Project)
Regional Head,
Airport, Passenger,
Cargo &Security
Zydus Cadila, India
Janssen, Malaysia
Mead Johnson
Nutrition, Thailand
International
Air Transport
Association,
Singapore
Sanjit Singh
Lamba
Shakilla
Shahjihan
Shirley Xu
Head, Site Supply
Yu-Kyeong
Hwang
Managing Director,
Eisai Pharmaceuticals
Regional Director,
Government Affairs,
Asia-Pacific
Novartis Vaccines,
China
Director, Cell Therapy
Research Center
Doctors Without
Borders/Medecis
Sans Frontieres,
India
Nathan
Kothandaraman
Nyoman
Mahardika
Director, Market
Access & Government
Affairs
Director, South Asia
Supply Chain
Allen Baharaff
James Williams
Jeroze Dalal
Jin Shun
Kam Man Hui
Sagnik Sengupta
Chief Executive Officer
Non-Executive Director
and Former Chief
Executive Officer
General Manager,
Clinical Operations,
India & Pakistan
Deputy Group Director,
Research
General Manager,
Distribution
Dimerix Bioscience,
Australia
GlaxoSmithKline,
India
Director, Regulatory
Policy & Intelligence,
Japan – Asia-Pacific,
Abbvie
Singhealth,
Singapore
Bharat Serums and
Vaccines, India
Kathy Yu
Nilesh Wadhwa
Pankaj Monga
Pik Pin Goh
Rajesh Pednekar
Silver Chen
Swapnil Ballal
Tom Geimer
Victoria Elegant
Yee Leong Teoh
Senior Director,
Business Development
& Strategy
Regional Director,
Business Development
& Strategy
Director, Brand
Protection (Asia),
Director
Head, Distribution
Vice President,
Medical, Clinical,
Regulatory Affairs
Chief Executive Officer
Merck Serono,
China
Takeda
Pharmaceticals,
Singapore
Pfizer
Pharmaceuticals,
India
Senior Director, Quality
Assurance
Managing Director
Clinical Research
Center, Ministry of
Health, Malaysia
Senior Director,
Regional Access Lead,
Asia-Pacific/China
Galmed
Pharmaceuticals,
Israel
Johnson & Johnson,
India
Singapore
Singapore
Green Cross LabCell,
South Korea
Abbott, Singapore
Pfizer, Hong Kong
Biocon, India
Madeline
Pharmaceuticals,
Australia
Baxter International,
China
Singapore Clinical
Research Institute
(SCRI), Singapore
Premium
conference
Day One
LICENSING
Tuesday 24 March 2015
Non-column purification to improve
process economy
14.30
Cross-border technology transfer
14.50
• Accelerating drug discovery via Moderna’s messenger RNA therapeutics™
• Addressing unmet global medical needs by “undruggable targets”
• Commercializing pioneering platform technologies globally
Stephan Bancel, President & Founding Chief Executive Officer, Moderna Therapeutics, USA
Listed in CNBC’s 2014 top 50 disruptors worldwide with its mRNA Therapeutics, “reprogramming cells to fight disease”
15.10
• Creating an innovative workplace with a top-down approach
• Increasing risk appetite for greater innovation and eminent results in drug development
• Case study: Change and growth at Toyota Motors & applications to the pharma industry
David Gallon, Director, Strategic Insight & Innovation, Toyota Financial Services, USA
Learning from the automotive industry—Defining the big word, “innovation”
TRACK 2
TRACK 3
TRACK 4
MARKET ACCESS
CELL CULTURE
CLINICAL DEVELOPMENT
SUPPLY CHAIN MANAGEMENT
Nathan Kothandaraman, Director,
Market Access & Government Affairs,
Janssen, Malaysia
Novel cell line development strategies
for monoclonal antibody production
Chi Wei-Kuang, Distinguished
Scientist, Bioengineering Group,
Development Centre for
Biotechnology, Taiwan
11:40
Silver Chen, Senior Director, Regional
Access Lead, Asia-Pacific, Pfizer, Hong
Kong
Cellular immunotherapy manufacturing
facilities
Government initiatives to develop
Malaysia as a clinical hub
Pik Pin Goh, Director, Clinical
Research Centre, Ministry of Health,
Malaysia
Role of academic research organisations
in clinical trials
Cargo security & pharma regulations: An
IATA perspective
Yee Leong Teoh, Chief Executive
Officer, Singapore Clinical Research
Institute (SCRI), Singapore
Vinoop Goel, Regional Head,
Airport, Passenger, Cargo &Security,
International Air Transport
Association, Singapore
Bringing early stage clinical research to
Asia
Realising flexible supply chain through
postponement strategy
James Garner, Head, Unit Development
Operations, Asia R&D, Sanofi, Singapore
Rajesh Pednekar, Head, Distribution
Pfizer, India
Nilesh Wadhwa, Regional Director,
Business Development and Strategy,
Takeda Pharmaceuticals, Singapore
Steven S. Lee, Global Head, Technical
Operations & Chief Executive Officer,
Singapore Operations, Dr. Reddy’s
Laboratories, Singapore
Jeroze Dalal, Head, Clinical Operations,
India & Pakistan, GlaxoSmithKline,
India
Leslie Chaney, Senior Director,
Commercial Operations APAC, Global
Director, Preclinical and Direct to Patient
Services, Marken, USA
Roundtable discussions: Flip to page 14 to see the roundtable moderators
Table A: Pricing and reimbursement
strategies in Japan, Korea and Australia
Table A: Strategic high quality cell
culture production and manufacturing
Table A: Clinical outsourcing models in
Japan, Korea and Australia
Table A: Reverse logistics
Table B: Pricing and reimbursement
strategies in China and India
Table B: Raw material testing &
handling
Table B: Clinical outsourcing models in
India & China
Table B: Managing 3PLs in a
complicated supply chain network
Table C: Pricing and reimbursement
strategies in Singapore & Malaysia
Table C: Decontamination technologies
for cell culture growth
Table C: Clinical outsourcing models in
Singapore & Malaysia
Table C: Improving clinical supply
importation and exportation
Qualified validation processes for cold
chain storage equipment
Debashis Basu, Head, Supply Chain,
Roche Diagnostics, India
Cold chain data management
Clinical supply chain efficiency in
emerging markets
Nyoman Mahardika, Director, South
Asia Supply Chain, Mead Johnson
Nutrition, Thailand
Ensuring subject safety and data quality
through risk-based monitoring (RBM)
Anticipating temperature excursions
during regional transport through risk
management strategy
Javed Rashid, Chief Scientific Officer
& Head, Medical (Pharmaceuticals),
Novartis, Singapore
Sanjit Singh Lamba, Managing
Director, Eisai Pharmaceuticals, India
New PCM pre-conditioning methods
for reliable, deterministic and optimal
performance of modern thermal
packaging solutions in a total quality
system
Contact Kenneth Lai at +65 6322 2792 or [email protected] to explore speaking opportunities in these sessions
Roundtable discussions: Flip to page 14 to see the roundtable moderators
Table A: In-licensing
Table A: Process monitoring and
statistical process control
Table A: Applications of next-generation
sequencing in clinical trials
Table A: Creating an unbroken cold
chain
Table B: Out-licensing
Table B: Continuous downstream
processing
Table B: Pan-Asian clinical trials
coordination
Table B: Human error in cold chain
Table C: Technology transfer
Table C: Emerging analytical technology
and methods in support of biologics
development & manufacturing
Table C: Adaptive trials design
Table C: Demand forecast for cost
effective cold chain practices
16.50
Afternoon refreshments I Exhibition visit I 1-to-1 Partnering
QUALITY BY DESIGN (QbD)
17.40
Contact Kenneth Lai at +65 6322 2792 or [email protected] to explore speaking opportunities in these sessions
Networking luncheon I Exhibition visit I 1-to-1 Partnering
Packaging your drugs for lucrative outlicensing deals
Pradip M Patel, Vice President & Head
– Vaccine (Operations & Project), Zydus
Cadila, India
Sanjay Desai, Director, Supply Chain,
Thermo Fisher Scientific, Singapore
Industry update: Trends & challenges in
supply chain logistics
12:00
Jim Miller, Vice President & Head,
Biologics Drug Substance Manufacturing
Network, Genentech, USA
Supply chain segmentation
15.50
Preparing your product for Malaysia in
the absence of reimbursement policies
Xiang Yang Zhu, Chief Executive
Officer, Huaota Biopharm, China
Cost-containment measures in Asia
12.20
Kathy Yu, Senior Director, Business
Development and Strategy, Merck
Serono, China
Is India still a desired destination for
clinical trials?
COLD CHAIN
Fabian Eschenbach, Business Unit
Manager Thermal Packaging, va-Q-tec,
Germany
17.20
Shakilla Shahjihan, Regional Director,
Government Affairs, Asia-Pacific,
Abbott, Singapore
Stable cell lines for higher expression
level of biotherapeutics
15.30
TRACK 1
Access to innovation and technology for
pharmas
13.20
Panel Discussion: Defining the
capabilities and limits for single-use
technology
CLINICAL OPERATION
Morning refreshments I Exhibition visit I 1-to-1 Partnering
18.00
10:30
18.20
11:00
11:20
Speed networking - Sponsored by:
Pete Gagnon, Senior Research
Technology Specialist, Downstream
Processing Group, Bioprocess Technology
Institute, Agency for Science,
Technology and Research (A*STAR),
Singapore
Key elements in structuring effective
deals in China
Making people’s lives better through change, innovation & growth
09:30
10:00
Jimmy Zhang, Vice President,
Transaction, Asia Pacific, Johnson &
Johnson Innovation Center, China
Combating diseases with disruptive mRNA technology
09:00
DOWNSTREAM PROCESSING
Analytical Quality by Design (AQbD) methods
development using platform approach
Jianmei Kochling, Director, Quality Science and
Analytical Technology, Genzyme, USA
DATA MANAGEMENT
TRANSLATIONAL MEDICINE
Understanding translational medicine & global
translational medicine situation
Big data for gene sequencing
Aamir Shahzad, President,
European Society for Translational Medicine
(EUSTM), Austria
Translational development from pre-clinical to human
QbD: Risk-based vs non-QbD
Web-based crowdsourcing for clinical trials
Jessie Gu, Head, Translational Medicine China,
Novartis Institute for Biomedical Research, China
Generation of variants in QbD
Holistic approaches for serialization
James Sutter, BioProcess Sciences Downstream
Process, Merck, Switzerland
Pankaj Monga, Director, Brand Protection, Asia,
Janssen, India
Translating imaging technology to discover and develop
biomarkers
Chih-Liang Chin, Director and Site Lead, Imaging,
MSD, Singapore
Contact Kenneth Lai at +65 6322 2792 or [email protected] to explore speaking opportunities in these sessions
18.40
End of Conference Day 1 & BioPharma Awards Dinner 2015
Treating neurodevelopment disorder in children with
translational medicine
Afaf El-ansary, Professor, King Saud University,
Saudi Arabia
Premium
conference
Day Two
Roundtable discussions: Flip to page 14 to see the roundtable moderators
Wednesday 25 March 2015
12:35
Table C: Regulatory approval for clinical
trials in Singapore and Malaysia
The end of copycat China
09:00
13.35
The rise of creativity, innovation and individualism in Asia
11.55
11.35
Patient access via collaboration
Marcus Klein, Senior Director and
Regional Medical Officer, Japan & AsiaPacific, Genzyme, Singapore
Gaining orphan drug designations in Asia
Hearing from the big pharma: Pfizer’s
perspective on development of
biosimilars in Asia
Ira Jacobs, Oncology Portfolio Global
Medical Lead, Biosimilars, Pfizer, USA
REGULATIONS
Global regulatory compliance of QbD
strategies
Jun Matsumoto, Principal Reviewer,
Office of Cellular and Tissue-based
Products, Pharmaceutical and
Medical Devices Agency (PMDA),
Japan
TRACK 4
GENERICS
Development of competitive generics
in Asia
Sreedhar Sagi, Head, Risk management
compliance officer, Sandoz, Singapore
Regulatory updates for trials in Asia
Patent expiry of generics
May Wei, Global Regulatory Strategist,
Bayer Healthcare, China
Victoria Elegant, Vice President,
Medical, Clinical, Regulatory Affairs,
Baxter International, China
Leena Menghaney, Head, Access
Campagin, South Asia, Doctors without
Borders, India
Increasing awareness of biosimilars: A
marketing perspective
IND submission and approval in Japan
Generic drug user fee amendment and
its impact on the pharma industry
Global biosimilars regulatory compliance
June Low, Business Unit Head,
Oncology & Biosimilars, Sandoz,
Singapore
Koike Satoshi, Director, Regulatory
Affairs, Japan, Amgen Astellas
Biopharma KK, Japan
14.50
BIOSIMILARS
TRACK 3
Quality by Design (QbD) tools for
pandemic influenza vaccine development
Kiyean Nam, Chief Executive Officer,
Qurient, South Korea
Pradip M Patel, Vice President & Head,
Vaccine (Operations & Project), Zydus
Cadila, India
James Huang, Managing Partner,
Kleiner Perkins Caufield Byers
(KPCB), China
Amit Kakar, Head, Healthcare, Asia,
Avenue Capital Group, Hong Kong
COMPLIANCE
Audits and inspections in Asia-Pacific
Angeline Lau, Regional Manager,
Clinical & Medical Quality Operations,
Sanofi Pasteur, Singapore
Therapeutic vaccine development using a
novel adjuvant
Aligning supply chain strategies with the
EU GDP and China’s GSP regulations
Jung Sun Yum, Director, CHA Vaccine
Institute, South Korea
Michael Lee, Vice President,
Operations, Lohmann, Taiwan
Academic’s priorities in industrial
collaboration
15.10
Commercial value of orphan drugs to
Asian pharmas
TRACK 2
VACCINES
Panel discussion: Cashing-in on Asia’s
promising biotechs
Allen Baharaff, Chief Executive Officer,
Galmed Pharmaceuticals, Israel
15.30
11.15
ORPHAN DRUGS
12.15
14.30
Morning refreshments I Exhibition visit I 1-to-1 Partnering
TRACK 1
Networking luncheon I Exhibition visit I 1-to-1 Partnering
PARTNERING MODELS
Advancing Asia’s biopharmaceuticals industry
• The historical tsunami—Rising significance of Asian markets and emerging Asian pharmas
• Business growth opportunities for global and Asian pharmas in Asia
• Strategies to exploit growth market in Asia
Christopher Gallen, President, SK Biopharmaceuticals, Korea
Transforming a spin-off to seize the global marketplace
10:30
Table C: Generics manufacturing quality
control
Table C: Biosimilars and biobetters
development
Table D: Implementing CLIA in clinical
operations
• The conventional role of China in the global pharma industry—Quantity over quality
• Fostering innovation in China’s pharma market to break away from the copycat market
• Introducing innovation to the market through new pharma partnership models
Shaun Rein, Managing Director, China Market Research Group, China
09:45
Table C: Reimbursement schemes for
orphan drugs in Asia
Michael Rossbach, Head, Strategic
Alliances, Business Development &
Scientific Programme Management,
Genome Institute of Singapore,
Singapore
Balancing costs and quality in packaging
Clinical evaluation of vaccines
Cedric Dubois, Head, China Industrial
Operations, Sanofi Pasteur, China
CELL / GENE THERAPY
Ex-vivo expanded allogenic natural killer
cell for cancer therapy
Yu Kyeong Hwang, Director, Cell
Therapy Research Centre, Green Cross,
LabCell, KIorea
Combating cancer through early
diagnosis and targeted therapy: a case
study of human hepatocellular carcinoma
(HCC)
Kam Man Hui, Deputy Group Director,
Research, SingHealth, Singapore
Development of Wnt pathway inhibitors
for cancer therapy
David Marc Virshup, Professor and
Director, Cancer and Stem Cell Biology,
Duke-NUS, Singapore
Contact Kenneth Lai at +65 6322 2792 or [email protected] to explore speaking opportunities in these sessions
Roundtable discussions: Flip to page 14 to see the roundtable moderators
Bobby George, Vice President and
Head, Regulatory Affairs, Reliance Life
Sciences, India
Table A: Risk assessment & exit
strategies for biotech investors
Table A: Vaccine access for developing
nations
Table A: Best GDP practices in Asia
Table A: Embryonic stem cells research
and applications
Table B: Capital raising strategies for
biotech start-ups
Table B: Single use-technology in
vaccines manufacturing
Table B: Best GMP practices in Asia
Table B: Cell therapy for cancer
treatment
Table C: Public private partnerships
Table C: Patient recruitment & retention
for vaccines trials
Table C: Best GCP practices in Asia
Table C: Stem cells treatment for
cancers
Contact Kenneth Lai at +65 6322 2792 or [email protected] to explore speaking opportunities in these sessions
15:50
Roundtable discussions: Flip to page 14 to see the roundtable moderators
Table A: Translating biosimilar market
trends into sound production strategies
Table A: Regulatory approval for clinical
trials in Japan, Korea and Australia
Table A: Innovative R&D for generics
12:35
Table A: Patient recruitment & retention
strategies for orphan drug trials
Table B: Patient outreach initiatives for
rare disease communities
Table B: Regulatory requirements for
biosimilars manufacturing
Table B: Regulatory approval for clinical
trials in China and India
Table B: Marketing & distribution
initiatives for generics
16.50
Afternoon refreshments I Exhibition visit I 1-to-1 Partnering
17.30
End of conference
Roundtable
discussions
Roundtable discussions Day 2: Pick one roundtable session from this timeslot
Table A:
Table A:
Translating biosimilar market trends
into sound production strategies
Roundtable discussions are available for premium pass conference holders. You can choose a
roundtable in each of the different time slots. Popular topics tend to fill up quickly, so we suggest
you book your ticket early!
Patient recruitment & retention
strategies for orphan drug trials
Atul Deshpande, Associate Director,
Unit Strategy Officer Asia Pacific
TSU, Sanofi, China & Julien Zhao,
Manager, Asia Biosimilar & Emerging
Biotech Markets,Process Solutions,
Merck Millipore, China
Table A:
Table A:
Regulatory approval for clinical trials
in Japan, Korea and Australia
Koike Satoshi, Director, Regulatory
Affairs, Japan, Amgen Astellas
Biopharma KK, Japan
Innovative R&D for generics
Roundtable discussions Day 1: Pick one roundtable session from this timeslot
Day 1, 12:20 – 13:20
Pricing and reimbursement strategies
in Japan, Korea and Australia
Table B:
Pricing and reimbursement strategies
in China and India
Silver Chen, Senior Director,
Regional Access Lead, Asia-Pacific,
Pfizer, Hong Kong
Table C:
Pricing and reimbursement strategies
in Singapore & Malaysia
Nathan Kothandaraman, Director,
Market Access & Government Affairs,
Janssen, Malaysia
Table A:
Table A:
Hybrid manufacturing for cell culture
production
Amol Kataria, Research Associate,
Intas Pharmaceuticals Limited,
India & Barbara Paldus, Chief
Executive Officer, Finesse, USA
Table B:
Raw material testing & handling
Swapnil Ballal, Senior Director,
Quality Assurance, Biocon, India
Table C:
Decontamination technologies for cell
culture growth
Table A:
Reverse logistics
Clinical outsourcing models in Japan,
Korea and Australia
Table B:
Clinical outsourcing models in China
and India
Jeroze Dalal, General
Manager, Clinical Operations,
GlaxoSmithKline, India
Hacene Mekerri, Managing
Director, Asia Pacific, Global Data
Management, LabCorp, Clinical
Trials, China
Table C:
Clinical outsourcing models in
Singapore & Malaysia
Yee Leong Teoh, Chief Executive
Officer, Singapore Clinical
Research Institute (SCRI),
Singapore
Rajesh Pednekar, Head,
Distribution Pfizer, India
Table B:
Managing 3PLs in a complicated
supply chain network
Day 2, 12.35 – 13.35
Table B:
Table A:
Patient outreach initiatives for rare
disease communities
Table C:
Table B:
Regulatory requirements for
biosimilars manufacturing
Samuel Raj Solomon, Senior
Manager & Head, Biosimilars
International Regulatory Affairs,
Biocon, India
Table C:
Table B:
Table B:
Regulatory approval for clinical trials
in China and India
Victoria Elegant, Vice President,
Medical, Clinical, Regulatory Affairs,
Baxter International, China &
Bobby George, Vice President &
Head, Regulatory Affairs, Reliance
Life Sciences, India
Table C:
Marketing & distribution initiatives
for generics
Table C:
Regulatory approval for clinical trials
in Singapore and Malaysia
Shirley Xu, Head, Site Supply,
Novartis Vaccines, China
Partnering in Biosimilar development
Reimbursement schemes for orphan
drugs in Asia
Table C:
Karen Wen, Chief Executive Officer,
Mycenax Biotech, Taiwan &
Laurent Rebier, Director, Business
Development, Biosimilars, Merck
Serono, Switzerland
Shun Jin, Director, Regulatory Policy
& Intelligence, Japan – Asia-Pacific,
Abbvie, Singapore
Generics manufacturing quality
control
Table D:
Implementing CLIA in clinical
operations.
Philip D Cotter, Prinicpal & Cofounder, Research Dx, USA
Improving clinical supply importation
and exportation
Edwin Sia, Associate Director,
Logistics, Asia Pacific, Quintiles,
Singapore
Pick one roundtable session from this timeslot
Table A:
Table A:
Table A:
Table A:
Pick one roundtable session from this timeslot
Process monitoring and statistical
process control
In-licensing
Kathy Yu, Senior Director, Business
Development and Strategy, Merck
Serono, China
Day 1, 15:50 – 16:50
Table A:
Table B:
Pankaj Gour, Downstream expert
MS&T, Novartis BiopharmOps,
Singapore
Table B:
Out-licensing
Nilesh Wadhwa, Regional Director,
Business Development & Strategy,
Takeda Pharmaceuticals,
Singapore
Table C:
Technology transfer
Continuous downstream processing
Swapnil Ballal, Senior Director,
Quality Assurance, Biocon, India
Table C:
Emerging analytical technology and
methods in support of biologics
development & manufacturing
Jianmei Kochling, Director, Quality
Science and Analytical Technology,
Genzyme, USA
Table A:
Applications of next generation
sequencing in clinical trials
Matthew Moore, Ph.D Principal &
co-founder, ResearchDx, USA
Table B:
Pan-Asian clinical trials coordination
Karen Wai, Senior Director, ISS,
Head, Site Services, Quintiles,
Singapore
Table C:
Adaptive trials design
Hye Jin Choi, Senior Director,
Regulatory Affairs, & Study StartUp, Asia-Pacific, ICON Clinical
Research, South Korea
Table A:
James Huang, Managing Partner,
Kleiner Perkins Caufield Byers
(KPCB), China
Creating an unbroken cold chain
Debashis Basu, Head, Supply
Chain, Roche Diagnostics, India
Table B:
Human error in cold chain
Shirley Xu, Head, Site Supply,
Novartis Vaccines, China
Table C:
Demand forecast for cost effective
cold chain practices
Sagnik Sengupta, General
Manager, Distribution, Bharat
Serums and Vaccines, India
Day 2, 15:50 – 16:50
Table A:
Risk assessment & exit strategies for
biotech investors
Table B:
Best GDP practices in Asia
Vaccine access for developing nations
Table B:
Capital raising strategies for biotech
start-ups
Single use-technology in vaccines
manufacturing
Kiyean Nam, Chief Executive Officer,
Qurient, South Korea
Jim Miller, Vice President &
Head, Biologics Drug Substance
Manufacturing Network, Genentech,
USA
Table C:
Table C:
Sanjay Desai, Director, Supply
Chain, ThermoFisher Scientific,
Singapore
Table B:
Embryonic stem cells research and
applications
Aamir Shahzad, President,
European Society for
Translational Medicine (EUSTM),
Austria
Table B:
Cell Therapy for cancer treatment
Best GMP practices in Asia
Table C:
Yu Kyeong Hwang, Ditrector, Cell
Therapy Research Center, Green
Cross LabCell, South Korea
Table C:
Public private partnerships
Tom Geimer, Managing Director,
Madeline Pharmaceuticals,
Australia
Patient recruitment & retention for
vaccines trials
Best GCP practices in Asia
Stem cells treatment for cancers
Workshops
Purchase a 3 day pass and you can join two workshops on 23 March 2015. The workshops will
be in small groups, led by an industry expert giving you the chance to meet other professionals
working in a similar field and get an in-depth understanding of the topics.
Choose one from the morning and one from the afternoon. Go to the biopharma website to see
up to date workshop agendas and leaders.
Morning:
Afternoon:
Designing innovative clinical trials
• Learn how to eliminate failures in trials by
focusing on the details in clinical trial design
• Move away from copy-the-last
protocols and high-variance designs
Pricing strategies for biopharmaceuticals in
Best practices in cold chain
management in Asia
• Learn how to manage temperature in biologic
storage and transportation
• Optimise product integrity of biological
products at low cost and high efficiency
Creating sustainable biomanufacturing plant
with single use technologies
• Learn how to use the latest tools to
implementing single use technology in
existing plants
• Learn strategies to streamline the
manufacturing process using single use
technology
Positioning your R&D pipelines as an
attractive investment
• How best to package your pipelines to get a
lucrative deal
• Learn how to maximize your share in the
global market as an Asian biotech.
emerging markets
• Learn sound pricing strategies to commercialise
your blockbuster drugs in Asia’s emerging
markets.
• How to stress value to make your drug
appealing to an emerging market
Networking
We’ve created ample opportunities for you to network with the other attendees at the
BioPharma Asia Convention; many of them are included in the premium conference agenda, but
you can join us at these additional activities as well.
1-2-1 Partnering
Participate in the speed networking sessions to put faces to names and
arrange follow ups.
On site, we have meeting room facilities for you to host private business
meetings.
Remember, if you can’t catch someone on site, you can use the app to send
messages and meeting requests.
Welcome Cocktail Reception
Achieving excellence in biologic manufacturing
with continuous improvement
• Learn about the adoption of QbD in
biomanufacturing as well as other operation
excellence strategies which can be applied
in creating efficient biologic manufacturing
process
• Learn how to motivate employees, streamline
manufacturing processes and minimise
production waste
Clinical trials outsourcing in Asia
• Learn how to select your partners, domestic/
regional CROs with the right specialisations
• Successfully manage a mutually beneficial
relationship with your CROs and local
counterparts
Using big data analysis to streamline supply
chain practices
• How to use big data to enhance supply chain
efficiency and minimise waste
• Learn more on optimising supply chain
operations to minimising cost and maximize
profit
If you think you’re an expert in any of these fields and want to lead a workshop, contact Kenneth today at
+65 6322 2792 or [email protected]
To join these workshops, book your 3 day pass online now at www.terrapinn.com/biopharma or call +65 6322 2701
Network with the other attendees over a complimentary cocktail. Get to know
the delegates you’ll be spending the next couple of days with and make some
initial introductions. This is open to all premium conference pass holders. RSVP
required
23 March, 7.00pm – 8.30pm, Secret venue (confirmed upon registration)
Networking app
Download the networking app to get organised and get in touch with all
attendees months before the event begins
Use the app:
• Plan your sessions
• Build a personalised agenda
• Identify exhibitors to visit
• Set up onsite meetings with key executives
• Network with other attendees
Keep your messages, meeting schedules and session agenda at your fingertips. You can continue to
use this networking tool for a full year after the event so you can follow up with anybody you missed
months down the line.
Contact us today on +65 6322 2770 to confirm your attendance at these networking activities and purchase premium
conference passes
Who’s attending
Benitec
Chief Executive Officer
Australia
Dimerix Bioscience Pty
Non Executive Director And Former Chief Executive Officer
Australia
HepSeeVax
Managing Director
Australia
Imugene
Exeuctive Director
Australia
Mariposa Health
Managing Director
Australia
Pfizer Australia Pty
Senior Director and Head, External R&D Innovation, Australia, New Zealand and Singapore
Australia
Starpharma
Chief Executive Officer
Australia
E.U.S.T.M.
President
Austria
Baxter International
Vice President, Medical, Clinical, Regulatory Affairs
China
Bayer Healthcare
Global Regulatory Strategist
China
Beijing Minhai Biotech
Vice President R&D
China
CANbridge Life Sciences
Chief Executive Officer
China
China Market Research Group
Managing Director
China
Covance
Senior Clinical & Ancillary Supplies Manager, Asia Pacific
China
Gproan Protein Engineering
Chief Executive Officer
China
HuaBo Biopharm
Co-Founder and Chief Executive Officer
China
Huaota Biopharm
Chief Executive Officer
China
Immuon Therapeutics
Chief Executive Officer
China
Kanghong Sagent (Chengdu) Pharmaceutical
Chief Executive Officer
China
KBP Biosciences
Senior. Vice President of Clinical Research and Chief Medical Officer
China
KBP Biosciences
Founder, President, Chairman
China
KBP Biosciences
Vice President, Pharmacology
China
Kleiner Perkins Caufield and Byers
Managing Partner
China
Lingmed
Business Development Manager
China
Merck Serono
Senior Director, Business Development & Strategy
China
NeuPharma
Chief Executive Officer
China
Novartis
Head, Site Supply
China
Novasep
Sales Director
China
Roche
Senior Automation Engineer
China
Roche
Unit Lead, Manufacturing IT
China
Sanofi
Associate Director, Unit Strategy Officer, Asia Pacific TSU
China
Sanofi Pasteur
Head of China Industrial Operations
China
Sotio
Chief Operating Officer
China
Suzhou Connect Biopharmaceuticals
Chief Executive Officer
China
Tarrex Biopharma
Chief Operating Officer
China
Yisheng Biopharma
Chief Financial Officer
China
Merck Serono
Business Development Manager
Peoples Republic Of China
Merck Serono
Business Development Director
Peoples Republic Of China
Novartis China
Head, Translational Medicine China
Peoples Republic Of China
Techpool Bio Pharma
Plant Director
Peoples Republic Of China
va-Q-tec Ag
Chief Engineer and Business Unit Manager, Thermal Packaging
Germany
Vetter Pharma International GmbH
Vice President
Germany
Vetter Pharma International GmbH
Director, Business Development Asia
Germany
Txcell
Venture Partner
Germany
Colder Products Company
Marketing and Customer Service Manager
Hong Kong
ICON Clinical Research
Marketing Manager, APAC
Hong Kong
MabSpace Biosciences
Chief Executive Officer
Hong Kong
Pfizer
Senior Director, Regional Access Lead Asia-Pacific/China
Hong Kong
Biocon
Senior Manager and Head, Biosimilars International Regulatory Affairs
India
Biocon
Head, Quality Assurance - Biologics
India
Biological E
Associate Director
India
Eisai
Managing Director
India
GlaxoSmithKline
Head Clinical Operations
India
GlaxoSmithKline
General Manager, Clinical Operations, India & Pakistan
India
Indchemie Health Specialities Pvt. Ltd
General Manager, Distribution
India
Indus Biotech
Managing Director
India
Intas Biopharmaceuticals
Research Associate, Cell Line Development
India
Invictus Oncology
Associate Director - R&D
India
Johnson & Johnson
Director, Brand Protection, Asia
India
Lambda Therapeutic Research Limited
AVP, Business Development
India
Doctors Without Borders
Head Access, South Asia
India
Novalead Pharma
Vice President, R&D
India
Novartis
Associate Clinical Distribution Manager
India
Pfizer
Head Distribution
India
PLUSS
Director Business Development
India
Sun Pharmaceuticals
Head Supply Chain
India
Takeda Pharmaceuticals
Regional Director Business Development & Strategy
India
West Coast Pharmaceutical Works
Managing Director
India
Wockhardt Limited
Associate Vice President and Head Legal
India
Zydus Cadila
Vice President and Head Vaccine Manufacturing
India
Stem Cell and Cancer Institute
Manager R&D
Indonesia
Stem Cell and Cancer Institute
Principal Investigator
Indonesia
Galmed Pharmaceuticals
Chief Executive Officer
Israel
Pluristem
Chairman and Chief Executive Officer
Israel
Amgen Astellas BioPharma KK
Director, Regulatory Affairs
Japan
Kaytee Bio
Chief Executive Officer
Japan
Morunda K.K.
Representative Director
Japan
Pharmaceutical and Medical Device Agency PMDA
Principal Reviewer
Japan
Clinical Investigation Centre, University of Malaya
Head Research Unit
Malaysia
Clinical Research Malaysia
Director
Malaysia
Eli Lilly
ASEAN Medical Director
Malaysia
Janssen
Director, Market Access & Government Affairs
Malaysia
Sentinext Therapeutics
Chief Executive Officer
Malaysia
European Patent Office
Patent Examiner
Netherlands
Sinensis Life Sciences BV
Chief Business Officer
Netherlands
Viroclinics Biosciences B.V
Marketing and Communication Officer
Netherlands
Curonz
Chief Scientific Officer
New Zealand
Alteogen
Chief Executive Officer
Republic Of Korea
Qurient (formerly Quro Science)
Chief Executive Officer
Republic Of Korea
S.K. Biopharmaceuticals
Chief Executive Officer
Republic Of Korea
TransPerfect
Account manager
Republic Of Korea
King Saud University
Professor
Saudi Arabia
Abbott
Regional Director, Government Affairs, Asia Pacific
Singapore
Abbott Nutrition Research & Development
Clinical Project Manager
Singapore
Abbott Nutrition Research & Development
Director, Clinical Research
Singapore
AbbVie
Site Manager
Singapore
AbbVie
Medical Director, South Asia
Singapore
AbbVie
Regional Medical Operations Manager Japan, APAC
Singapore
Aik Moh Paints & Chemicals
Business unit head
Singapore
Asia Cold Chain Centre
Chief Executive Officer and Principal Consultant
Singapore
Astellas Pharma
RA QA & PV Manager
Singapore
Austrianova Singapore
Head Research and Development
Singapore
B.T.I
Staff Scientist, Animal Cell Technology
Singapore
Baxter
Senior manager Planning & Deployment
Singapore
Baxter Bioscience
Head Manufacturing
Singapore
Baxter BioScience Manufacturing SARL
Manufacturing Engineer
Singapore
Baxter Bioscience Manufacturing SARL
Process Engineer
Singapore
Baxter Healthcare Asia
Senior Manager Operations and Compliance
Singapore
Bayer
Senior Regulatory Affairs Associate
Singapore
Bayer
Head Supply Coordination Asia Pacific
Singapore
Bioprocessing Technology Institute
Senior Research Technology Specialist
Singapore
Bioprocessing Technology Institute
Research Officer
Singapore
Bioprocessing Technology Institute
Research Scientist
Singapore
Boehringer Ingelheim
Clinical Operations Quality Manager
Singapore
Boehringer Ingelheim
Regional Clinical Operations Therapeutic Area Leader
Singapore
Celgene
Associate Manager, Logistics & Supply Chain
Singapore
Ciba Vision
Head Procurement
Singapore
Who’s attending
Clearbridge Accelerator
Senior Investment Manager
Singapore
Prime Biologics
Director Regulatory Affairs and Quality Assurance
Singapore
ClinActis
Chief Executive Officer
Singapore
PSS
Manager
Singapore
Clinical Imaging Research Centre
Quality Assurance Manager
Singapore
Quintiles
Associate Director Logistics
Singapore
Dr. Reddy's Laboratories
Global Head, Technical Operations & CEO, Singapore Operations
Singapore
Sanofi
Head, Unit Development Operations, Asia R&D
Singapore
Duke NUS
Program Director, Cancer Stem Cell & Biology
Singapore
Sanofi
Director of Operation, Asia-Pacific R & D
Singapore
Sanofi Pasteur
Regional Manager, Clinical & Medical Quality Operations
Singapore
Eli Lilly & Company
Quality Auditor
Singapore
Eli Lilly & Company
QA Consultant
Singapore
Sanofi Pasteur
Regional Clinical Trial Manager
Singapore
Eli Lilly & Company
Lead Consultant, Global Medical Quality
Singapore
SDV Logistics
Quality Assurance Executive, Pharmacist
Singapore
ELPRO-BUCHS AG
Market Research Manager
Singapore
Servier
Regulatory Affairs Manager
Singapore
GlaxoSmithKline
Vice President
Singapore
Shire
Regional Medical Lead, Internal Medicine
Singapore
Genome Institute of Singapore
Manager, Strategic Alliances
Singapore
Singapore Clinical Research Institute
Chief Executive Officer
Singapore
Genzyme
Senior Director & Regional Medical Officer, Japan - Asia-Pacific
Singapore
Singapore Clinical Research Institute
Chief Medical Officer
Singapore
Genzyme
Regional Regulatory Affairs Manager
Singapore
Singapore Clinical Research Institute
Head, Project Management
Singapore
Glaxo Wellcome Manufacturing
Head of external ventures
Singapore
Singapore Immunology Network (SIgN)
Principal Investigato
Singapore
GlaxoSmithKline
Director Emerging Markets, R&D
Singapore
Sirtex
Regional Medical Director, Asia Pacific
Singapore
Global Airfreight International
Senior Executive
Singapore
Taiho Pharma
Medical Affairs Manager
Singapore
GlaxoSmithKline
Chemical Engineer, Manufacturing
Singapore
Taiho Pharma
Clincal Research Manager
Singapore
Hays Life Sciences
Consultant
Singapore
Takeda Development Center
Asia Regional Head, Regulatory Affairs
Singapore
Hospira
QA Manager, SEA/HK
Singapore
Takeda Development Center
Associate Director, Clinical Operations, Asia Therapeutic Area Lead
Singapore
HSBC Institutional Trust Services (Singapore)
Marketing Manager
Singapore
Takeda Development Centre
Clinical Study Manager
Singapore
Institute of Bioengineering and Nanotechnology
Principal Research Scientist
Singapore
Takeda Pharmaceuticals
Regional Director, Business Development and Strategy
Singapore
Institute of Materials Research and Engineering
Scientist
Singapore
Takeda Vaccines
Senior Scientist
Singapore
Institute of Medical Biology, A*STAR
Strategic Alliances Manager
Singapore
Teva Pharmaceutical Investments
Regional Regulatory Affairs Manager (APAC)
Singapore
Institute of Medical Biology, A*STAR
Project Manager
Singapore
Thermo Fisher Scientific
Director Supply Chain Asia
Singapore
InVivos Pte Ltd
Business Development Manager
Singapore
UCL
Medical Representative
Singapore
Johnson & Johnson
Regional Regulatory Affairs Director
Singapore
Debiopharm International S.A.
Associate Director Head of Licensing
Switzerland
Johnson and Johnson Consumers
Asia Pacific External Manufacturing ? Source
Singapore
Haselmeier GmBH
Sales Assistant
Switzerland
Lilly-NUS
Managing Director
Singapore
Development Center for Biotechnology
Director, CGMP BPPF
Taiwan
Lonza Biologics
Technical Investigator
Singapore
Lohmann
Vice President, Operations
Taiwan
Lonza Biologics
Purification Scientist
Singapore
Mead Johnson Nutrition
Director, South Asia Supply Chain
Thailand
Lonza Biologics
Process Engineer
Singapore
RitzCarlton
Auditor
United Arab Emirates
Lonza Biologics
Senior Section Lead (MSAT)
Singapore
Barrington James
Director
United Kingdom
Merck Sharp & Dohme
Director, Supply Chain Management
Singapore
Dotmatics
Head - Enterprise Partnering
United Kingdom
MerckGroup
Distribution Manager - Chemicals
Singapore
Avenue Capital Group LLC
Head, Healthcare, Asia
United States
Metrohm Singapore
Chief Sales Officer (Europe), Spectroscopy Group
Singapore
Catalent Pharma Solutions
Tradeshow
United States
Metrohm Singapore
Managing Director
Singapore
eResearchTechnology Inc
Senior Vice - President - Asia - Pacific
United States
Morgan McKinley
Consultant
Singapore
Finesse Solutions, LLC
Asia Pacific Sales Manager
United States
Merck Sharp & Dohme/ Translation Medicine Research Centre
Director and Site Lead, Imaging
Singapore
Genentech
Vice President and Head, Biologics Drug Substance Manufacturing Network
United States
Mundipharma
Manager, Regulatory Affairs, Asia
Singapore
Genentech
Director of Manufacturing Operations
United States
National Cancer Centre Singapore
SingHealth Deputy Group Director, Research
Singapore
Johnson & Johnson
Vice President of Transactions
United States
National University of Singapore
Student
Singapore
Johnson & Johnson
Vice President, Transactions, Asia-Pacific
United States
Novartis
Senior Expert Infrastructure and HVAC Site Services
Singapore
KBI Biopharma
Vice President, Business Development
United States
Novartis
Downstream Expert - MS and T
Singapore
LabCorp
Marketing Manager
United States
Novartis Institute for Tropical Diseases
Investigator III
Singapore
Marken
Global Director for Direct to Patient Services
United States
Novartis Oncology
Chief Scientific Officer and Head of Medical (Pharma Division)
Singapore
Marken
Vice President Commercial Operations Asia Pacific
United States
Novartis
Head, Site Engineering, Biopharm Operations
Singapore
MN Thermal Science
Marketing Communications Director
United States
Novartis
Site Quality Head BiopharmOps Singapore
Singapore
Moderna Therapeutics
President & Founding Chief Executive Officer
United States
Novartis
Project Director
Singapore
Pfizer
Oncology Portfolio Global Medical Lead-Biosimilars
United States
Novartis
Process Specialist MS&T
Singapore
Quintiles
Director of Global Marketing
United States
Novartis
Downstream Technician
Singapore
ResearchDx
Principal
United States
NUHS Tissue Repository
Medical Technologist
Singapore
S.G. Research International
President
United States
National University of Singapore
Research Assistant
Singapore
Sanofi Pasteur
Deputy Director, Mtech/AP&T - Extractables & Leachables
United States
Parker domnick hunter
Technical Support Engineer
Singapore
SNBL USA
Director of Business Development - APAC
United States
Pfizer
Senior Supply Chain Specialist
Singapore
Toyota
Director, Strategic Insight & Innovation
United States
Pfizer
Supply Chain Specialist
Singapore
Bayer HealthCare
Country Head and Bayer HealthCare Representative
Vietnam
PrIME Biologics
Manager, IT and Facilities
Singapore
International Air Transport Association
Regional Head, APCS
Freemium
conference
Day One
Theatre One
Theatre Two
Asian Biotech Theatre
Clinical trials in stem cells & regenerative medicines
Suzhou Connect Biopharmaceuticals, China
Tuesday 24 March 2015
Zheng Wei, Chief Executive Officer
3.20
Clinical trials for diabetes
Prevalent diseases in Asia
Theatre One
Theatre Two
Asian Biotech Theatre
3.40
Clinical trials for degenerative neurology
Galmed, Israel
Allen Baharaff, Chief Executive Officer
Facility & process design
11.00
Vaccines
Man or machine? The balance between company’s money
and morale
David Lawrence, Chief Executive Officer
Best facility designs for aseptic Biomanufacturing
HepSeeVax, Australia
Barbara Paldus, CEO, Finesse, USA
Serina Cucuzza, Managing Director
Statistical process monitoring in biosimilar production
Pankaj Gour, Downstream expert MS&T, Novartis Biopharm
Ops, Singapore
12.20
Vijay Nag Thota, Head, Analytical Quality & Regulatory,
SciGen BioPharma, India
Clinical trials on stem cell therapies for heart disease
4.40
Clinical trials on stem cell therapies for ultra rare diseases
CuroNZ, New Zealand
Frank Sieg, Chief Scientific Officer
Kaytee Bio, Japan
Kensei Tsuzaka, Chief Executive Officer
Sentinext Therapeutics, Malaysia
Jogesh Bhole, Senior Expert, Infrastructure & HVAC-Site
Services, Novartis, Singapore
12.00
4.20
Wei Wenjin, Vice President, R&D
HVAC in good clean room design
11.40
Clinical trials for rheumatoid arthritis
Beijing Minhai Biotechnology, China
Rajnish Narula, Production Director, Pfizer, Singapore
11.20
4.00
Research symposium hosted by:
Japan Analytical Instruments
Manufacturers Association
Chengdu Kanghong Pharmaceuticals, China
Chen Su, Chief Executive Officer
Pluristem, Israel
5.00
Zami Aberman, Chief Executive Officer
ImmuOn Therapeutics, China
End of day one
John Wang, Chief Executive Officer
Continuous process verification
Imugene, Australia
Nick Ede, Managing Director
Manufacturing Technologies
12.40
1.00
1.20
Optimising tangential flow filtration unit operations
Adopting micro carriers to grow cells in suspension culture
Qualitative high throughput analytics to support
polysaccharide biologic production
Freemium
conference
Yisheng Biopharma, China
Day Two
David Shao, Chief Financial Officer
Analytical diagnostics
Forum
hosted by: Japan Analytical
Instruments Manufacturers
Association
Gproan Protein Engineering, China
Wednesday 25 March 2015
Haiqian An, Chief Executive Officer
MabSpace Biosciences, China
Xueming Qian, Chief Executive Officer
Theatre One
Theatre Two
Asian Biotech Theatre
Chronic Diseases
Clinical trials in Oncology
1.40
Disruptive technology-an alternative to protein A for mabs
production
Clinical trials for lung cancer
Research symposium Hosted
by: Singapore Immnunology
Network (SIgN), Singapore
Clinical trials for chronic myeloid leukemia
Visit the website for updated
information on this session
KBP Biosciences, China
Long Li, Vice President of Pharmacology
9.00
Quality Control
2.00
Implementing Total quality management (TQM) in pharma
manufacturing process
Anjali Mahajan, Manager, Biocon, India
9.20
Novalead Pharma, India
Advanced flow cytometry applications
Optimising the manufacturing process with lean 6
Sankar Dharmaraj, Senior Manager-Quality Leadership
Process Operation Excellence, Baxter Bioscience,
Singapore
Mariposa Health, Australia
Phillip Comans, Managing Director
10.00
Raw Material Identification in less than 30 seconds
2.40
3.00
Indus Biotech, India
Wim Guns, Chief Sales Officer, Spectroscopy Group,
Metrohm-NIRSystems, Singapore
Sunil Bhaskaran, Managing Director
Best facility for real time process monitoring
Neuclone, Australia
Bo Zhu, Senior Process Automation Engineer, Roche, China
Noelle Sunstrom, Chief Executive Officer
Reserved for Quintiles
Benitec Biopharma, Australia
Peter French, Chief Executive Officer
Huabo Biopharm, China
Wenzhi Tian, Chief Executive Officer
Chikungunya virus infection
Sudhir Kulkarni, Vice President, R&D
9.40
2.20
Oncology
Ken Pennline, Ph.D, Vice President & Global Head,
Cytometry Services, Labcorp, USA
Patent protection for personalized medicine in Europe using
PCT procedure
Fredrik Aslund, Patent Examiner, European Patent Office,
The Netherlands
Lisa Fong Poh Ng, Principal
Investigator
Invictus Oncology, India
Monideepa Roy, Vice President, R&D
Hepatitis B virus infection
Ren Ee Chee, Principal
Investigator
CANBridge Life Sciences, China
James Xue, Chief Executive Officer
Clinical trials in vaccines
10.20
Clinical trials for Malaria Vaccines
Qurient Therapeutics, Korea
Yisheng Biopharma, China
Kiyean Nam, Chief Executive Officer
Freemium
conference
Day Two
Wednesday 25 March 2015
Theatre One
10.40
11.00
Theatre Two
Asian Biotech Theatre
Clinical trials for Influenza Vaccines
Dengue virus infection
Tarrex Biopharma, China
Reserved for Viroclinics
Katja Fink, Principal Investigator
Kanyin Zhang, Chief Executive Officer
Clinical trials for hepatitis B vaccines
Reserved for CIC University of Malaya
Mycobacterium tuberculosis
infection
Amit Singhal, Project Leader
11.20
Clinical trials for HIV Vaccines
Tuesday, 24 March, 2015; 09:00-09:30am
NeuPharma, China
Warehousing & product distribution
Best practices in stock handling
12.00
Medigen Biotechnology, Taiwan
Sagnik Sengupta, General Manager, Distribution, Bharat
Serums and Vaccines, India
David Ma, Director, Business Development
Cold chain transportation in tropical countries
TTY Biopharm, Taiwan
Michael Lee, Vice President, Operations, Lohmann, Taiwan
Lily Lien, Associate Project Manager
Selecting the right 3PL in cold chain logistic
12.20
Alteogen, Korea
Sanjay Desai, Supply Chain Director, Thermo Fisher
Scientific, Singapore
Soon Jae Park, Chief Executive Officer
Raw material procurement in India
12.40
Bora Pharmaceuticals, Taiwan
Sanjit Singh Lamba, Managing Director, Eisai
Pharmaceuticals, India
Bobby Sheng, Chairman
Product integrity and supply chain security
Starpharma, Australia
Biopharmaceutical supply chain sustainability in Asia
1.00
Au Yang Sian, Senior Manager Planning & Deployment, Asia
Pacific, Baxter International, Singapore
1.20
Handling emergency cases when product integrity is
compromised due to mishandling
1.40
Shipment security: Marine & Air transportation
2.00
Outsourcing decision: warehousing activities and inventory
management
2.20
Smart Packaging
2.40
Product integrity during warehouse storage
3.00
End of Day Two
Jackie Fairley, Chief Executive Officer
Research symposium hosted by:
Stem Cells & Cancer Institute,
Indonesia
President & Founding Chief Executive Officer, Moderna Therapeutics, USA
Akiko Itai, Chief Executive Officer
Shawn Qian, Chief Executive Officer
11.40
Stephan Bancel
IMMD, Japan
Fungal infection
Norman Pavelka, Principal
Investigator
“MODERNA IS A
QUANTUM CHANGE.”
Listed as one of CNBC’s Disruptor 50 due to their novel drug applications, mRNA
Therapeutics, Moderna Therapeutics is revolutionising the biotech world by allowing
patients to build their own drugs.
The BioPharma Asia Convention is the most important pharma
conference in Asia year by year.
CELGENE
The BioPharma Asia
Industry Awards
“NOTHING IS EVER
TOO IMPORTANT TO FAIL”
Innovate. Impact. Inspire.
The 5th Biopharma Asia Industry Awards dinner celebrates 10 organisations/individuals for their
contributions and achievements to Asia’s burgeoning biologics industry.
David Gallon
Join over 250 biopharma a-listers at this year’s BioPharma Asia industry awards evening,
which promises to be a starry affair indeed.
ve
ati
ov ch
n
In ote
Bi
Director, Strategic Insight & Innovation, Toyota Financial Services, USA
O
ng
i
s
ni
g
co he
e
t
R
st
e
B
Asia
Mal n
Exe e
c
an
Asi an
m
o
W ec
Ex
Up
So str
lu eam
tio
n
Pharma
Tuesday, 24 March, 2015; 09:30-10:00 am
CR
CMO
LS
P
ld
Co ain
Ch
am
tre
ns ion
w
Do olut
S
STEP 1:
Vote online for the nominees at www.terrapinn.com/bio-asia/awards
STEP 2:
Book your ticket for the ceremony online today at
www.terrapinn.com/biopharmaasia
7.00pm – 9.30pm, 24 March 2015, Suntec Singapore Convention &
Exhibition Centre
Contact Kenneth Lai at +65 6322 2792 or [email protected]
www.terrapinn.com/bio-asia/awards
For years, David has been consulting the automotive industry on how to adopt
innovation by spotting social trends. To the pharma industry, where a single product
can take years of research and billions of costs, he encourages high risk appetite and
openness to failure and change.
Get involved
Be seen & heard
The Exhibition
• Be seen as an initiator in BioPharma
innovation.
• Secure your booth along the busy aisles to
generate maximum traffic
• Take the stage to showcase your expertise in
front of a pool of prospects
• Present a case study at the pharma value
chain development seminars
• Share your latest products and services to an
exhibition full of potential customers
NETWORKING LUNCHEON
& REFRESHMENTS
PREMIUM TRACK 4
• Network! Rub shoulders with warm leads and
key clients across Asia
• Secure a speaking slot in front of a receptive
audience of senior level decision makers in
the premium conference
• Pre-arrange 1-2-1 meetings with your
preferred client list
Who you will meet
COUNTRY
PAVILLION
C30
A27
A28
B27
A25
A26
B25
A23
A24
B23
MR6
MR7
C28
FREEMIUM
THEATRE 1
PREMIUM TRACK 1
FREEMIUM
THEATRE 2
C26
COUNTRY
PAVILLION
MR8
B20
MR5
C21
NETWORKING
LOUNGE
MR4
MR3
MR2
B16
C17
B14
C15
MR1
GENIE
BAR
ASIAN BIOTECH
SHOWCASE
F20
G21
F18
G19
F16
G17
F14
G15
Who should sponsor &
exhibit
• Contract service providers (CROs, CMOs,
CDMOs)
• CXOs from APAC biopharma brands
LOUNGE
• CXOs from biotechs and SMEs
• Decision makers across the APAC biopharma
value chain
PREMIUM TRACK 3
B08
C09
D12
C10
D11
D10
E09
E07
E10
F11
F10
G11
E08
F07
F08
G07
• Clinical research solution providers
PREMIUM TRACK 2
G08
C08
D07
D08
C04
D05
D04
E04
F05
F04
F05
G04
D02
E02
E03
F02
F03
G02
• Directors of the various biopharma verticals
B02
• Decision influencers and industry
stakeholders of the APAC Biopharma
Industry
SOLD
RESERVED
C02
• Host private luncheons, cocktails, seminars
with your pre-qualified guest list
• Lead roundtable discussions that show off
your expertise and industry knowledge
F24
C24
B18
• CXOs of APAC coming from international
biopharma brands
• Craft booth activities and leverage on our
marketing activities to increase your market
presence
• eClinical trials and big data management
solutions providers
• Manufacturing solution providers (upstream,
downstream)
• Facility HVAC, cleanroom and containment
equipment providers
• Country governments / trade agencies
• Legal and compliance firms
• Consultants and banks
Over 70% already sold
To book a booth, contact:
Kenneth Lai at +65 6322 2792,
[email protected]
• 3rd party logistics providers
• Cold chain packaging companies
• Distributors in Asia Pacific
• Executive search firms
• Laboratory equipment providers
The BioPharma Asia Opportunity
The BioPharma Asia Facts
You’ve got goals? We can help you achieve them. We can work with you to achieve your targets in 2015 by
positioning your brand in front of the Asia Pacific biopharmaceutical industry.
Who attends?
+
Engage with potential clients
Generate leads, leads and more leads!
•
Exhibit at the show
•
Market your whitepaper with Total BioPharma
•
Work out a visitor campaign with us
•
Leverage on lead generation activities
•
Host a dedicated closed door workshop to
reach your target audience
•
Network with potential clients without fighting
your competitors at a private luncheons
Pharma
•
Lead a roundtable discussion, hear industry
issues and present your solutions
•
Utilise the networking app and our networking activities
Biotech
RI
Brand your company and products
Be a thought leader and educator
•
Leverage on our social media channels to expand
your networks
Join a panel or moderate during discussion platforms
•
Write an e-book that promotes your industry
knowledge
Take up premium slots in the Total BioPharma
newsletter and gain maximum outreach through
our database
•
Get involved in our “new product, latest launch” ideas
Lead an interactive clinic within the conference agenda
•
Brand activities within the event that are aligned with your
company’s direction
•
Share a case study and discuss trends as a speaker
•
•
•
Benefits
Diamond
Platinum
Gold
Plenary forum moderator
1 day
Plenary presentation slot
1 x 20 mins
Networking socials sponsor
1
Private hospitality benefits
(private luncheon & cocktail sponsorship)
Yes
Yes
Lead generation via content E-book
1
1
Presentation slots
1
1
1
Lead generation via social media
campaign
4
3
2
Silver
Bronze
Exhibitor
CRO
CMO
Government
Consultant
Hospital
Investor
Where from?
Europe
Asia
17%
1
of the Wo
st
rld
Re
68%
5%
Host roundtable session
4
4
2
1
Onfloor value chain speaking sessions
3
3
2
1
1
Onsite and event marketing logo branding
Diamond
Platinum
Gold
Silver
Bronze
Exhibitor
Exhibition booth
36 sqm
24 sqm
18 sqm
12sqm
9sqm
9sqm
VIP Passes for company representatives
10
7
5
3
2
1
Passes to exhibition
10
6
6
4
3
2
VIP Passes for clients
15
10
8
5
3
3
Access to networking app
Unlimited
Unlimited
Unlimited
Unlimited
Unlimited
Unlimited
Price (SGD)
85,000 and
above
80,000
60,000
35,000
25,000
15,000
Contact Kenneth Lai to discuss sponsorship & exhibition opportunities on +65 6322 2792 or [email protected]
Australia
USA
3%
7%
Contact Kenneth Lai on +65 6322 2792 or
[email protected] to find out how you
can best profile your company at Asia’s
leading regional biopharma event.
2000
+
800
+
600
+
30
+
5
+
2
+
3
Industry
stakeholders
1-to-1
meetings
C-level
executives
Hours of
networking
Conference
brands
Research
symposiums
On-floor seminar
sessions
Event partners
GOLD SPONSOR
SILVER SPONSORS
BRONZE SPONSORS
knows your target
EXHIBITORS
MEDIA PARTNERS & ASSOCIATIONS
The BioPharma series
For decades, Terrapinn has been hosting BioPharma Conventions across the globe.
Leading international pharmaceutical and biotech companies as well as notable
industry figures have participated as keynote speakers and delegates across the
various conference agendas. These events have received the endorsement of long
established societies and associations and the support of some of the industry’s
biggest service providers. The BioPharma Conventions are highly prestigious amongst
industry professionals.
“NO LONGER CHEAP CHINA”
Shaun Rein
Managing Director, China Market Research Group and Author of The
End of Copycat China
Wednesday, 25 March, 2015; 09:00-09:45 am
Shaun tells you why the changing demographics in China means new business
opportunities and no more counterfeit goods.
19-21 October 2015,
Seoul Renaissance Hotel,
Seoul,South Korea
3-4 November 2015,
Mexico City, Mexico
9-10 November 2015,
23-25 March 2015,
The Lalit Mumbai, India
Suntec Singapore Convention &
Exhibition Centre, Singapore
Special discounts are available when booking for multiple events at one time. Call +65 6322 2770 to find out more